Breaking News
Get 45% Off 0
Selloff or market correction? Either way, here's what to do next
See Overvalued Stocks

Zacks Investment Research Zacks Investment Research

Zacks Investment Research's Opinion & Analysis.
Featured here: a complete archive of all posts and research produced by Zacks Investment Research, including current material.
Here Is Why Growth Investors Should Buy Chuy's (CHUY) Now By Zacks Investment Research - Mar 10, 2020

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to find...

Earnings Preview: AAR (AIR) Q3 Earnings Expected To Decline By Zacks Investment Research - Mar 10, 2020

AAR (AIR) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended February 2020. This widely-known consensus outlook gives a good...

Why Zoom Video (ZM) Might Be Well Poised For A Surge By Zacks Investment Research - Mar 10, 2020

Investors might want to bet on Zoom Video Communications (ZM), as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price...

Bitauto Holdngs (BITA) Upgraded To Buy: Here's Why By Zacks Investment Research - Mar 10, 2020

Bitauto Holdngs (BITA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates --...

BioCryst (BCRX) Upgraded To Strong Buy: Here's Why By Zacks Investment Research - Mar 10, 2020

BioCryst Pharmaceuticals (BCRX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in...

Continue with Apple
Continue with Google
or
Sign up with Email